# Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma

> **NCT06516133** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 494 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** Intensity modulated radiation therapy (IMRT) with conventional planning target volume (PTV) margin and without online adaptive radiotherapy
- **DRUG:** Chemotherapy
- **RADIATION:** Intensity modulated radiation therapy (IMRT) with smaller planning target volume (PTV) margin and online adaptive radiotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06516133
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-17
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 494 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06516133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06516133, "Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06516133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*